These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25454856)

  • 1. Why German farmers have their animals vaccinated against Bluetongue virus serotype 8: results of a questionnaire survey.
    Gethmann J; Zilow V; Probst C; Elbers AR; Conraths FJ
    Vaccine; 2015 Jan; 33(1):214-21. PubMed ID: 25454856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Questionnaire survey about the motives of commercial livestock farmers and hobby holders to vaccinate their animals against Bluetongue virus serotype 8 in 2008-2009 in the Netherlands.
    Elbers AR; de Koeijer AA; Scolamacchia F; van Rijn PA
    Vaccine; 2010 Mar; 28(13):2473-81. PubMed ID: 20123141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expected utility of voluntary vaccination in the middle of an emergent Bluetongue virus serotype 8 epidemic: a decision analysis parameterized for Dutch circumstances.
    Sok J; Hogeveen H; Elbers AR; Velthuis AG; Oude Lansink AG
    Prev Vet Med; 2014 Aug; 115(3-4):75-87. PubMed ID: 24768508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and cost-benefit study to encourage herd owners in a cost sharing vaccination programme against bluetongue serotype-8 in Belgium.
    Cargnel M; Van der Stede Y; Haegeman A; De Leeuw I; De Clercq K; Méroc E; Welby S
    Transbound Emerg Dis; 2019 Jan; 66(1):400-411. PubMed ID: 30281942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
    Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
    Zulu GB; Venter EH
    J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
    Feenstra F; Pap JS; van Rijn PA
    Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.
    Celma CC; Stewart M; Wernike K; Eschbaumer M; Gonzalez-Molleda L; Breard E; Schulz C; Hoffmann B; Haegeman A; De Clercq K; Zientara S; van Rijn PA; Beer M; Roy P
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative safety study of three inactivated BTV-8 vaccines in sheep and cattle under field conditions.
    Gethmann J; Hüttner K; Heyne H; Probst C; Ziller M; Beer M; Hoffmann B; Mettenleiter TC; Conraths FJ
    Vaccine; 2009 Jun; 27(31):4118-26. PubMed ID: 19410620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of antibodies against bluetongue virus serotype 8 in bulk-tank milk samples from dairy cattle herds located in risk areas for bluetongue virus transmission after a vaccination programme in Switzerland.
    Büchi M; Abril C; Vögtlin A; Schwermer H
    Berl Munch Tierarztl Wochenschr; 2014; 127(3-4):158-62. PubMed ID: 24693662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of bluetongue virus serotype 6 in Europe--German field data and experimental infection of cattle.
    Eschbaumer M; Hoffmann B; Moss A; Savini G; Leone A; König P; Zemke J; Conraths F; Beer M
    Vet Microbiol; 2010 Jul; 143(2-4):189-95. PubMed ID: 20045271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence after vaccination of cattle and sheep against Bluetongue Virus (BTV) serotype 8 in Sweden.
    Hultén C; Frössling J; Chenais E; Sternberg Lewerin S
    Transbound Emerg Dis; 2013 Oct; 60(5):438-47. PubMed ID: 22889362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaling from challenge experiments to the field: Quantifying the impact of vaccination on the transmission of bluetongue virus serotype 8.
    Gubbins S; Hartemink NA; Wilson AJ; Moulin V; Vonk Noordegraaf CA; van der Sluijs MT; de Smit AJ; Sumner T; Klinkenberg D
    Prev Vet Med; 2012 Aug; 105(4):297-308. PubMed ID: 22425328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the spatial and temporal distribution of and risk factors for Bluetongue serotype 1 epidemics in sheep Extremadura (Spain), 2007-2011.
    Pascual-Linaza AV; Martínez-López B; Pfeiffer DU; Moreno JC; Sanz C; Sánchez-Vizcaíno JM
    Prev Vet Med; 2014 Oct; 116(3):279-95. PubMed ID: 24929438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of Antibodies against Bluetongue Virus (BTV) in Sheep 5 to 7.5 Years after Vaccination with Inactivated BTV-8 Vaccines.
    Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Moeller B; Bastian M; Ganter M
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31181733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
    Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
    Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication of bluetongue disease in Germany by vaccination.
    Baetza HJ
    Vet Immunol Immunopathol; 2014 Mar; 158(1-2):116-9. PubMed ID: 24090604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with the occurrence of undesired effects in sheep and goats after field vaccination with modified-live vaccine against bluetongue virus serotypes 2, 4 and 16.
    Savini G; Cannas A; Casaccia C; Di Gialleonardo L; Leone A; Patta C; Nicolussi P
    Vet Microbiol; 2010 Nov; 146(1-2):44-50. PubMed ID: 20537822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.